This document discusses live cell therapy and stem cell nutrition. It summarizes that live cell therapy helps repair and regenerate cells to enhance immunity and reduce aging by delivering energy from live cells to aging cells. It also discusses that stem cells need only plant chemicals, which all plants and animals contain, including amino acids, glucose, fatty acids, vitamins, minerals, and water. The document then focuses on HemoHIM, a Korean herbal supplement that was developed to improve immune function. Studies found that HemoHIM stimulated red blood cell development, activated immune cells, and promoted immune recovery against oxidative stress with few side effects. HemoHIM was also found to prevent immune suppression in mice and reduce inflammation in a cigarette smoke
3. What is live cell therapy?
Cell Live therapy helps to repair and regenerate
human body Cell, and therefore enhances
immunity.
Cell degeneration causes ageing in human,
therefore by delivering energy from live cells to
ageing cells, it keeps human body young and
healthy.
4. Cell is tiny life.
Our body
comprises of 100
trillion of cells.
5.
6.
7.
8. Picture of a high quality expanded human blastocyst embryo 5 days after fertilization
The clump of cells in the 10 to 12 o'clock area is the inner cell mass (ICM) which become the fetusThe
trophectoderm cells (TE) that will form the placenta surround the fluid cavity
The fluid-filled blastocoel cavity is in the center
14. All the body cell same to look , same Biological function , only different execution
15.
16. Stem Cell needs only
Plant Chemicals
Only Plants produce
Plant Chemicals for
Stem Cell
17. All Plants of the nature synthesis & contain the following
Plant Chemicals
1.Amino acid
2.Glucose
3.Fatty acid
4.Vitamins
5.Minerals
6.Water
Alphabets of Plant
18. All Animals of the nature contain the following
Plant Chemicals
1.Amino acid
2.Glucose
3.Fatty acid
4.Vitamins
5.Minerals
6.Water
Alphabets of Animal
21. Only Plants compose Biochemical .
Animals (Human) eat Plants
We can say:
Six plant Chemicals are common
Alphabets & Bricks of Plants & Animals.
22. Well come to
A thinking of Modern Medication
By applying
StemCell Nutrition
23. StemCell NutritionTherapy will start
By providing :
1. Less Cooking Food 20%
2. Green Food 60%
3. Herbal Food
4. Herbal Medicinal Food
5. Herbal Medicine
24.
25. HemoHIM, is a Korean functional health food supplement developed through
biotechnology and radiation technologies from the food-life engineering team of the
Korea Atomic Energy Research Institute (KAERI). It was a government project supported
by the Ministry of Science and Technology, Korea, which spanned for 8 years, costing
them 5 billion won (roughly USD $4.7 million).To combat this, the research team
developed, the original, HemoHIM, prepared by a combination of three (3) edible
herbs: Angelica Radix, Cnidium Rhizoma and Paeonia Radix. It was found out that
HemoHIM is able to stimulate the development of red blood cells (RBC), activate
immune cells, as well as promoting recovery of the immune system against oxidative
stresses. Because HemoHIM has little or no toxic effects, it has an added advantage over
other synthetic compounds often prescribed for immune-related ailments. In addition,
existing immune drugs have specific targeted functions, whereas HemoHIM is able to
simultaneously target multiple immune-related symptoms. According to researcher
Sung-Kee Jo, HemoHIM has been approved not only by the Korea Food and Drug
Administration (KFDA) but also by US FDA as well, as the first health functional food for
immune system improvement. In a series of clinical studies conducted on CANCER
patients, healthy volunteers and university students, HemoHIM has shown to improve
recovery of white blood cells (WBC) increase interferon production and increase
lymphocytes in patients.
HemoHIM Benefits
26. We determined the functional effect of the herbal preparation, HemoHIM, on
the immune system, by examining the immunomodulatory activities of
HemoHIM using immunocompromised mice. In this study, to examine the
effect on the restoration of immune cells and balance in the immune system,
we utilized a cisplatin-induced immunosuppression mouse model. Mice were
injected intraperitoneally with cisplatin, an immunosuppressive anticancer, and
then received oral doses of 100, 250, and 500 mg/kg of HemoHIM for 14 days.
The HemoHIM prevented the cisplatin-induced loss of body and organ weight.
In terms of innate immunity, natural killer (NK) cell activity and phagocytosis
increased in the HemoHIM group compared to the cisplatin control group. The
HemoHIM group also showed a significantly higher expression of Th1-mediated
cytokines (interferon gamma (IFN-γ), interleukin-2 (IL-2), and tumor necrosis
factor alpha (TNF-α)) and inhibited the production of Th2-mediated cytokine
interleukin-4 (IL-4) compared to cisplatin control group. These findings indicate
that HemoHIM enhances immune activity by modulating immune cell activity
and cytokine secretion in immune-suppressed mice.
ResearchArticle | OpenAccess
Volume 2019 |Article ID 3494806 | https://doi.org/10.1155/2019/3494806
Preventive Effect of the Herbal Preparation, HemoHIM, on
Cisplatin-Induced Immune Suppression
27. HemoHIM, a herbal preparation, alleviates airway inflammation
caused by cigarette smoke and lipopolysaccharide.
Lab Anim Res. 2017 Mar; 33(1): 40–47.Published online
2017Mar27. doi: 10.5625/lar.2017.33.1.40PMCID: PMC5385281PMID: 28400838
HemoHIM, herbal preparation has designed for immune system recovery. We
investigated the anti-inflammatory effect of HemoHIM on cigarette smoke (CS) and
lipopolysaccharide (LPS) induced chronic obstructive pulmonary disease (COPD) mouse
model. To induce COPD, C57BL/6 mice were exposed to CS for 1 h per day (eight
cigarettes per day) for 4 weeks and intranasally received LPS on day 26. HemoHIM was
administrated to mice at a dose of 50 or 100 mg/kg 1h before CS exposure. HemoHIM
reduced the inflammatory cell count and levels of tumor necrosis factor receptor (TNF)-
α, interleukin (IL)-6 and IL-1β in the broncho-alveolar lavage fluid (BALF) induced by
CS+LPS exposure. HemoHIM decreased the inflammatory cell infiltration in the airway
and inhibited the expression of iNOS and MMP-9 and phosphorylation of Erk in lung
tissue exposed to CS+LPS. In summary, our results indicate that HemoHIM inhibited a
reduction in the lung inflammatory response on CS and LPS induced lung inflammation
via the Erk pathway. Therefore, we suggest that HemoHIM has the potential to treat
pulmonary inflammatory disease such as COPD.